Immunome, Inc.

Principal Scientist, Chemical Development

Immunome, Inc.  •  $170k - $206k/yr  •  Bothell, WA (Onsite)  •  10 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, supported by a leadership team with deep experience in the design, development, and commercialization of cutting-edge therapies, including antibody-drug conjugates. Our pipeline includes varegacestat, an investigational gamma secretase inhibitor for which an NDA has been accepted by the U.S. FDA; IM-1021, a clinical-stage ROR1 ADC; IM-1617, a clinical-stage solid tumor ADC; and IM-3050, a clinical-stage FAP-targeted radioligand therapy. We are also advancing a broad portfolio of early-stage ADCs pursuing undisclosed solid tumor targets.

We are seeking an experienced Principal Scientist, Chemical Development to join our dynamic team to help advance our pipeline of innovative targeted cancer therapies. The successful candidate will apply their expertise in small molecule process development and manufacturing to support a variety of modalities in the Immunome pipeline with a focus on small molecule linker-payload targets for ADCs. This person will play a key role in leading challenging drug candidate process development programs, enabling treatment of patients in need.

Responsibilities

Leadership

  • Provide technical leadership as a key member of the chemical development team while maintaining alignment with the company's goals and objectives
  • Function as the technical lead on at least one program while also functioning as an individual technical contributor.
  • Provide guidance and leadership to external partners working towards the successful advancement of antibody drug conjugates, radiopharmaceuticals, and other lead programs.
  • Support programs at the bench as an individual contributor as needed.

Technical Expertise

  • Leverage knowledge and experience in the development and execution of robust and scalable small molecule synthetic processes.
  • Devise and evaluate alternative routes of synthesis with the aim of developing robust and efficient routes to APIs while reducing cost of goods (COGs) and shortening manufacturing lead times.
  • Develop robust data packages for technical transfer of processes for manufacturing partners at external CMOs.
  • Maintain knowledge of the current state of the art in synthetic methods utilized for the construction of complex molecules.
  • Carry out thorough analytical data collection both as an individual contributor in the lab as well as via oversight and review of data collected at our external partners
  • Contribute to authoring relevant sections of various regulatory documents (IND, IMPD, NDA, briefing books, etc.) and provide SME support for related regulatory inquiries.

Cross-Functional Collaboration

  • Execute the integrated CMC regulatory strategies for pipeline programs.
  • Collaborate with research, regulatory affairs, and CMC teams to ensure seamless coordination of activities.
  • Provide feedback to research on synthetic routes and raw materials that are CMC friendly.
  • Foster strong collaborations with internal and external stakeholders.
  • Engage colleagues in discovery chemistry to provide CMC input of target molecules under evaluation for future development.

Innovation

  • Stay abreast of the latest advancements in synthetic methodology as well as new technologies and methodologies to enhance our capabilities.
  • Advance Immunome’s intellectual property portfolio.

Quality and Compliance

  • Ensure compliance with relevant regulatory guidelines and industry standards for chemical development processes.
  • Uphold high-quality standards and address any compliance issues.

Qualifications

  • PhD in Synthetic Organic Chemistry or similar with a minimum of 7 years of industry experience leading small molecule and/or linker-payload programs, or equivalent combination of education and experience.
  • Experience as a technical lead overseeing tech transfer, process development and implementation of processes for manufacture at internal and/or external manufacturers is a plus.
  • Occasional evening and/or weekend commitment.
  • Ability to travel domestically and internationally (5-15%).

Knowledge and Skills

  • Ability to design cost effective robust manufacturing processes for complex small molecule targets as well as troubleshoot and solve complex technical challenges quickly.
  • Brings a collaborative and open-minded attitude when working with various internal and external teammates.
  • Meticulous and detail-oriented scientist with the ability to operate as an individual contributor at the bench while also managing external partners.
  • Proficient in generating robust and reliable analytical data utilizing various technologies in a hands-on capacity as well as evaluation of analytical data generated at external partners.
  • Proficient in writing technical reports and formulating presentations
  • Ability to develop cross functional relationships with discovery chemistry and other pre-clinical groups.
  • Experience in leading and managing technology transfers to third party process development and manufacturing partners.
  • Knowledge of cGMP requirements and ICH guidelines related to CMC small molecule drug-substance development and manufacturing.
  • Track record of working closely with cross-functional teams in a biopharmaceutical or pharmaceutical environment.
  • Excellent interpersonal and communication skills.
Washington State Pay Range
$169,593$206,233 USD

E/E/O

Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.

E-Verify

Immunome, Inc. is a participant in E-Verify. Please review the following notices: E-Verify Participation Poster | Right to Work Poster (English) | Right to Work Poster (Spanish)

Immunome, Inc.

About Immunome, Inc.

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted therapies designed to improve outcomes for cancer patients. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting-edge targeted cancer therapies, including antibody-drug conjugate therapies (ADCs). Our most advanced pipeline programs are varegacestat (formerly AL102), a gamma secretase inhibitor which is currently in a Phase 3 trial for treatment of desmoid tumors; IM-1021, a ROR1-targeted ADC which is currently in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand, which recently received IND clearance. Our pipeline also includes IM-1617, IM-1335, and IM-1340, all of which are preclinical ADCs pursuing undisclosed targets with expression in multiple solid tumors.

Industry
Biotech & Life Sciences
Company Size
51-200 employees
Headquarters
Bothell, Washington
Year Founded
Unknown
Social Media